This creates a positive feedback loop and contributes to chemopreventive mechanism of vitamin D. Thus, genotyping the patients with cancer for mutations at serine residues 208/222 of VDR might be used for exclusion of these patients from vitamin D-directed anti-cancer therapy. Here, VDR is linked to cancer.